SEC FORM 4
$117,050.10
Amneal Pharmaceuticals, Inc. (AMRX)
Sale of 6,613 shares at $17.70 per share.
Reporting Person Daly Jason B. · Officer Title EVP, Chief Legal Officer · Transaction Code S
Traded Aug 11, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001628280-26-056754 · filed 2026-08-13 · View filing →